Bluejay Diagnostics, Inc.

BJDX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1,598-$1,957-$1,864-$1,432
Dep. & Amort.$32$38$52$37
Deferred Tax$0$0$0$0
Stock-Based Comp.$0-$2$1$0
Change in WC$218-$135$626$156
Other Non-Cash-$12$0$0-$500
Operating Cash Flow-$1,360-$2,054-$1,185-$1,739
Investing Activities
PP&E Inv.$0$0$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$1
Financing Activities
Debt Repay.-$1-$1-$1$286
Stock Issued$0$3,847$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$465$0-$0
Financing Cash Flow-$1$3,381-$1$286
Forex Effect$0$0$0$0
Net Chg. in Cash-$1,361$1,327-$1,186-$1,454
Supplemental Information
Beg. Cash$4,443$3,116$4,302$5,756
End Cash$3,082$4,443$3,116$4,302
Free Cash Flow-$1,360-$2,054-$1,185-$1,740
Bluejay Diagnostics, Inc. (BJDX) Financial Statements & Key Stats | AlphaPilot